Literature DB >> 26341113

Lipoprotein heterogeneity may help to detect individuals with insulin resistance.

Carlos Lorenzo1, Anthony J Hanley2,3, Marian J Rewers4, Andreas Festa5, Steven M Haffner6.   

Abstract

AIMS/HYPOTHESIS: The triacylglycerol (TG)-to-HDL-cholesterol ratio has been shown to detect insulin resistance. However, the added predictive value of a more comprehensive assessment of lipoprotein composition is unknown.
METHODS: We analysed cross-sectional data from 882 non-diabetic participants in the Insulin Resistance Atherosclerosis Study (IRAS). Lipoproteins were measured by nuclear magnetic resonance (NMR) spectroscopy. Determined by the frequently sampled intravenous glucose tolerance test, insulin resistance was defined as the lowest sex-specific quartile of insulin sensitivity.
RESULTS: The AUC of the receiver operating characteristic curve of HDL-cholesterol and TG levels for detecting insulin resistance was similar to that of the TG-to-HDL-cholesterol ratio (0.676 vs 0.673; p = 0.685), but smaller than the AUC of NMR-detected lipoproteins (0.676 vs 0.745; p < 0.001). NMR lipoproteins added discriminative value to HDL-cholesterol and TG levels (net reclassification improvement of 40.0%; p < 0.001; and integrated discrimination improvement of 9.5%; p < 0.001), with net benefit within predicted probabilities of between 10% and 50% by Vickers' decision-curve analysis. We also demonstrated additive value to demographic variables, BMI and levels of fasting glucose, TG, and HDL-cholesterol (net reclassification improvement of 14.0%; p < 0.001; and integrated discrimination improvement of 4.5%; p < 0.001). CONCLUSIONS/
INTERPRETATION: NMR lipoproteins, which can be measured in the fasting state, add information to the TG and HDL-cholesterol ratio across a broad range on insulin resistance. Depending on the other risk factors of insulin resistance that are incorporated, NMR lipoproteins permit the correct reclassification of an additional 14-40% of individuals.

Entities:  

Keywords:  Clinical science; Epidemiology; Human; Insulin sensitivity; Lipids; Lipoproteins

Mesh:

Substances:

Year:  2015        PMID: 26341113     DOI: 10.1007/s00125-015-3743-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  39 in total

1.  Black-white differences in serum lipids and lipoproteins in Evans County.

Authors:  H A Tyroler; C G Hames; I Krishan; S Heyden; G Cooper; J C Cassel
Journal:  Prev Med       Date:  1975-12       Impact factor: 4.018

2.  New metrics for assessing diagnostic potential of candidate biomarkers.

Authors:  John W Pickering; Zoltan H Endre
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 8.237

Review 3.  Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide.

Authors:  Maarten J G Leening; Moniek M Vedder; Jacqueline C M Witteman; Michael J Pencina; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2014-01-21       Impact factor: 25.391

4.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

5.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study.

Authors:  S M Haffner; R D'Agostino; D Goff; B Howard; A Festa; M F Saad; L Mykkänen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

7.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

8.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

9.  Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.

Authors:  Nancy R Cook; Paul M Ridker
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

10.  Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.

Authors:  Anette Varbo; Marianne Benn; Anne Tybjærg-Hansen; Børge G Nordestgaard
Journal:  Circulation       Date:  2013-08-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.